As of November 6, 2026, SeaStar Medical Holding Corp has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from June 23, 2026 to July 1, 2026 (Form 8-K, July 1, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like SeaStar Medical Holding Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
SeaStar Medical Holding Corp reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-06-23 to 2026-07-01. Every row below is cited to the filing it comes from, and this page adds each new change as SeaStar Medical Holding Corp files it.
Also on the record for SeaStar Medical Holding Corp
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 8, 2026 | Form D, private offering | $3.30M sold | Form D page | Source |
| May 13, 2026 | Stake report, Schedule 13G/A, by Mitchell P. Kopin | 9.99% of the class | 5%+ stakes | Source |
| May 11, 2026 | Stake report, Schedule 13G, by Ayrton Capital LLC | 6.52% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Mitchell P. Kopin | 9.99% of the class | 5%+ stakes | Source |
| November 7, 2025 | Stake report, Schedule 13G/A, by Mitchell P. Kopin | 9.99% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 4.99% of the class | 5%+ stakes | Source |
| August 13, 2025 | Stake report, Schedule 13G/A, by Ayrton Capital LLC | 2.6% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs SeaStar Medical Holding Corp now and the warning signs.
Free to see. No signup.
Keep reading
More on SeaStar Medical Holding Corp and the records around it.
SeaStar Medical Holding Corp elsewhere on the record
- Company profile and every filing Oct 2026
- Form D filing Oct 2026
- 5%+ stake filings May 2026
- Who owns it
Companies that share a holder
- Ayrton Capital LLC also filed stake reports on 31 other companies: Bluejay Diagnostics, Inc. (Aug 2026), BTC Digital Ltd. (Aug 2026), DEFSEC Technologies Inc. (Aug 2026)
- Mitchell P. Kopin also filed stake reports on 55 other companies: SCWorx Corp. (Sep 2026), NFT Limited (Aug 2026), Silexion Therapeutics Corp (Aug 2026)
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Watch SeaStar Medical Holding Corp
Get an email when SeaStar Medical Holding Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on SeaStar Medical Holding Corp?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on SeaStar Medical Holding Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SeaStar Medical Holding Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
9 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-07-01 | Reported | not named in the filing | 8-K, 2026-07-01 | ||
| 2026-06-23 | Reported | not named in the filing | 8-K/A, 2026-06-23 |
New leaders reset buying decisions — get the Full Report on SeaStar Medical Holding Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportWatch SeaStar Medical Holding Corp (free up to 3)
Find people with the same kind of experience as the senior executive at SeaStar Medical Holding Corp, with the record behind each one.
Find candidates like senior executive at SeaStar Medical Holding CorpEvery change, in the filing's words
Reported
If an Executive departs prior to the applicable vesting date, no future payments will be made.
- On June 25, 2026, the Compensation Committee of the Board of Directors of the SeaStar Medical Holding Corporation (the "Company") approved retention bonuses for each of Eric Schlorff and Kevin Chung ("Executives") in the amount set forth below, (a) one-third of which will vest and be payable on July 1, 2026, (b) one-third of which will vest and be payable on November 1, 2026, and (c) one-third of which will vest and be payable on March 1, 2027, in each case subject to continued employment through the applicable vesting date.
- Executives will receive an additional amount equal to 25% of each payment in shares of the Company's common stock under the Company's 2022 Omnibus Incentive Plan, with the number of shares being determined based on the share price at the close of business on each applicable vesting date.
- If an Executive is separated from the Company without cause, he will receive a pro-rata amount for the then current upcoming payment.
- These bonuses were part of a broader retention program affecting additional long-serving Company employees.
- On June 29, 2026, the Company entered into a 2026 Retention Bonus Program Agreement with each of the Executives (the "Agreements').
Reported
Departure of Directors or Certain Officer; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
- On June 10, 2026, SeaStar Medical Holding Corporation (the "Company") and Mr. Green entered into a separation and release agreement releasing all claims surrounding the disputed not-for-cause termination referenced in the 8-K signed on August 19, 2025, with a mutual resolution, pursuant to which SeaStar has agreed to pay Mr. Green more than what was previously disclosed in the 8-K signed on August 19, 2025.
SeaStar Medical Holding Corp's funding history
Tools for this story
Each opens in a new tab, filled in for SeaStar Medical Holding Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.